Market news — every asset we track

Assets

TARA

Protara Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will present at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026, at 2:00 pm ET. A live webcast of the presentation can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.c

Sep 8Yahoo Finance

TARA

Protara Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update

Aug 11Yahoo Finance

TARA

Protara Therapeutics: Orphan Drug Indications Drive A Heavily Undervalued Pipeline

Aug 11Seeking Alpha

TARA

What Makes Protara Therapeutics (TARA) a New Buy Stock

Protara Therapeutics (TARA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Jul 21Yahoo Finance

TARA

This is the newest page. Registered accounts read further back.